Is it time to change the follow-up guidelines for early BC - aka - is it worthwhile to detect metastatic disease earlier? (ABC6)


E-session 592007

Expert
Ann H. Partridge'
Dana-Farber Cancer Institute
Boston, USA

This e-Session is part of the following pathway(s):
01
Nov 2021

Material selected from